CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 90 filers reported holding CTI BIOPHARMA CORP in Q4 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $19,000 | – | 8,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST NEW YORK SECURITIES LLC /NY | 191,000 | $345,710,000 | 0.34% |
| TFS CAPITAL LLC | 1,182,304 | $2,140,000 | 0.21% |
| TURNER INVESTMENTS LLC | 530,100 | $959,000 | 0.17% |
| DRW Securities, LLC | 486,953 | $881,000 | 0.14% |
| Candriam S.C.A. | 1,445,000 | $2,616,000 | 0.05% |
| First Heartland Consultants, Inc. | 74,624 | $135,000 | 0.05% |
| WASHINGTON TRUST Co | 410,616 | $743,000 | 0.05% |
| EAGLE ASSET MANAGEMENT INC | 4,332,630 | $7,842,000 | 0.04% |
| JW Asset Management, LLC | 52,271 | $95,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 702,571 | $1,272,000 | 0.03% |